Theriva Biologics Inc (TOVX)
1.63
+0.33
(+25.38%)
USD |
NYAM |
Dec 24, 11:43
Theriva Biologics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | -3.845B |
| Pro-Dex Inc | -0.431M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.913M |
| Cash from Financing (Quarterly) | 3.716M |
| Free Cash Flow | -18.84M |
| Free Cash Flow Per Share (Quarterly) | -3.449 |
| Free Cash Flow Yield | -1.41K% |